FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306912460> ?p ?o ?g. }

• W4306912460 endingPage "1111" @default.
• W4306912460 startingPage "1111" @default.
• W4306912460 abstract "Oncologic treatment is costly to the health care system and to individuals, but patients with head and neck cancer (HNC) also have long-term care needs after treatment. Survivors of HNC require specific consideration given their rapidly growing numbers. This subpopulation of cancer survivors often experiences long-term treatment-associated morbidity.To describe the total and out-of-pocket (OOP) costs associated with HNC survivorship and the risk factors for financial toxicity among this population.This was a retrospective review and economic evaluation of a cohort of US adults with a diagnosis of HNC from 2006 to 2018. The study used data the from IBM MarketScan Commercial Claims Database. Data were analyzed from November 2020 to June 2022.Treatment for HNC.Total and OOP medical costs were assessed monthly and reported relative to the date of HNC diagnosis. The primary outcome was the difference between a patient's mean monthly survivorship costs (13-60 months after diagnosis) and mean monthly baseline costs (7-12 months before diagnosis). Univariate and multivariable linear regression models were created for total and OOP costs to generate coefficient estimates with 95% CIs.The study cohort of this economic evaluation included 19 098 patients with HNC (median [range] age, 56 [18-64] years; 14 144 [74.1%] men and 4954 [25.9%] women; race and ethnicity were not considered). Throughout the survivorship period, median total and OOP costs were $372 per month and $31 per month higher than baseline costs, respectively, with variation in expenses by demographic information, health plan type, and oncologic variables. In the multivariable model, greater total and OOP excess survivorship costs were associated with female sex ($343/mo; 95% CI, $126 to $560 and $9/mo; 95% CI, $4 to $14). Highest and lowest total excess survivorship costs associated with cancer site were seen for hypopharyngeal ($1908/mo; 95% CI, $1102 to $2714) and oropharyngeal cancers (-$703/mo; 95% CI, -$967 to -$439) vs oral cavity cancers. Compared with surgery or radiation therapy alone, multimodal treatment was generally associated with excess OOP survivorship costs.The findings of this retrospective economic evaluation review suggest that the costs of HNC survivorship remain persistently elevated above baseline costs for at least 5 years after diagnosis. High survivorship costs were associated with female sex, hypopharyngeal tumors, and treatment with multimodal therapy. Practitioners should seek to minimize costs for these patients at higher-risk of financial toxicity after treatment and work to provide directed supportive services." @default.
• W4306912460 created "2022-10-21" @default.
• W4306912460 creator A5007458509 @default.
• W4306912460 creator A5039678358 @default.
• W4306912460 creator A5054722262 @default.
• W4306912460 creator A5065144608 @default.
• W4306912460 creator A5084264697 @default.
• W4306912460 date "2022-12-01" @default.
• W4306912460 modified "2023-10-17" @default.
• W4306912460 title "Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship" @default.
• W4306912460 cites W1973715482 @default.
• W4306912460 cites W1997009145 @default.
• W4306912460 cites W2057780602 @default.
• W4306912460 cites W2069179442 @default.
• W4306912460 cites W2110664940 @default.
• W4306912460 cites W2134170718 @default.
• W4306912460 cites W2143680521 @default.
• W4306912460 cites W2151311059 @default.
• W4306912460 cites W2154735291 @default.
• W4306912460 cites W2170915815 @default.
• W4306912460 cites W2301857081 @default.
• W4306912460 cites W2305033403 @default.
• W4306912460 cites W2510564515 @default.
• W4306912460 cites W2533574559 @default.
• W4306912460 cites W2605574960 @default.
• W4306912460 cites W2766534898 @default.
• W4306912460 cites W2771051044 @default.
• W4306912460 cites W2794452383 @default.
• W4306912460 cites W2803751141 @default.
• W4306912460 cites W2810172375 @default.
• W4306912460 cites W2884331737 @default.
• W4306912460 cites W2886833531 @default.
• W4306912460 cites W2893092082 @default.
• W4306912460 cites W2893774254 @default.
• W4306912460 cites W2917069934 @default.
• W4306912460 cites W2940897767 @default.
• W4306912460 cites W2943077196 @default.
• W4306912460 cites W2948158248 @default.
• W4306912460 cites W2955031832 @default.
• W4306912460 cites W2964372340 @default.
• W4306912460 cites W2997089336 @default.
• W4306912460 cites W3028385412 @default.
• W4306912460 cites W3031013398 @default.
• W4306912460 cites W3033718997 @default.
• W4306912460 cites W3040329245 @default.
• W4306912460 cites W3049846243 @default.
• W4306912460 cites W3082081404 @default.
• W4306912460 cites W3137861363 @default.
• W4306912460 cites W4221015909 @default.
• W4306912460 cites W4240607235 @default.
• W4306912460 cites W4241045680 @default.
• W4306912460 cites W4241412768 @default.
• W4306912460 cites W4245477361 @default.
• W4306912460 cites W4249261328 @default.
• W4306912460 cites W4249314923 @default.
• W4306912460 cites W4255996274 @default.
• W4306912460 cites W4281717747 @default.
• W4306912460 cites W4319425389 @default.
• W4306912460 doi "https://doi.org/10.1001/jamaoto.2022.3269" @default.
• W4306912460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36264567" @default.
• W4306912460 hasPublicationYear "2022" @default.
• W4306912460 type Work @default.
• W4306912460 citedByCount "4" @default.
• W4306912460 countsByYear W43069124602023 @default.
• W4306912460 crossrefType "journal-article" @default.
• W4306912460 hasAuthorship W4306912460A5007458509 @default.
• W4306912460 hasAuthorship W4306912460A5039678358 @default.
• W4306912460 hasAuthorship W4306912460A5054722262 @default.
• W4306912460 hasAuthorship W4306912460A5065144608 @default.
• W4306912460 hasAuthorship W4306912460A5084264697 @default.
• W4306912460 hasConcept C121608353 @default.
• W4306912460 hasConcept C126322002 @default.
• W4306912460 hasConcept C144024400 @default.
• W4306912460 hasConcept C149923435 @default.
• W4306912460 hasConcept C160735492 @default.
• W4306912460 hasConcept C162324750 @default.
• W4306912460 hasConcept C167135981 @default.
• W4306912460 hasConcept C172400760 @default.
• W4306912460 hasConcept C194828623 @default.
• W4306912460 hasConcept C2776530083 @default.
• W4306912460 hasConcept C2908647359 @default.
• W4306912460 hasConcept C50522688 @default.
• W4306912460 hasConcept C71924100 @default.
• W4306912460 hasConcept C72563966 @default.
• W4306912460 hasConcept C74909509 @default.
• W4306912460 hasConcept C99454951 @default.
• W4306912460 hasConceptScore W4306912460C121608353 @default.
• W4306912460 hasConceptScore W4306912460C126322002 @default.
• W4306912460 hasConceptScore W4306912460C144024400 @default.
• W4306912460 hasConceptScore W4306912460C149923435 @default.
• W4306912460 hasConceptScore W4306912460C160735492 @default.
• W4306912460 hasConceptScore W4306912460C162324750 @default.
• W4306912460 hasConceptScore W4306912460C167135981 @default.
• W4306912460 hasConceptScore W4306912460C172400760 @default.
• W4306912460 hasConceptScore W4306912460C194828623 @default.
• W4306912460 hasConceptScore W4306912460C2776530083 @default.
• W4306912460 hasConceptScore W4306912460C2908647359 @default.
• W4306912460 hasConceptScore W4306912460C50522688 @default.

• next